Guidance on strain changes in authorised COVID-19 vaccines

According to new guidance  from ACCESS Consortium, a coalition of regulatory authorities from UK, Australia, Canada, Singapore & Switzerland, authorised COVID-19 vaccines modified in response to new variants will not  need a brand new  approval or “lengthy” clinical studies.

Source:

Medicines and Healthcare products Regulatory Agency